Purpose/Objectives: To describe quality-of-life (QOL) concerns particular to women with ovarian cancer and to examine whether subgroups of patients with ovarian cancer have significantly different QOL concerns.
Dow, K.H., Ferrell, B.R., Leigh, S., Ly, J., & Gulasekaram, P. (1996). An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Research and Treatment, 39, 261-273.
Ersek, M., Ferrell, B.R., Dow, K.H., & Melancon, C.H. (1997). Quality of life in women with ovarian cancer. Western Journal of Nursing Research, 19, 334-350.
Ferrell, B., Smith, S., Cullinane, C., & Melancon, C. (2003a). Symptom concerns of women with ovarian cancer. Journal of Pain and Symptom Management, 25, 528-538.
Ferrell, B., Smith, S.L., Cullinane, C.A., & Melancon, C. (2003b). Psychological well being and quality of life in ovarian cancer survivors. Cancer, 98, 1061-1071.
Ferrell, B.R., Dow, K.H., & Grant, M. (1995). Measurement of the quality of life in cancer survivors. Quality of Life Research, 4, 523-531.
Ferrell, B.R., Dow, K.H., Leigh, S., Ly, J., & Gulasekaram, P. (1995). Quality of life in long-term cancer survivors. Oncology Nursing Forum, 22, 915-922.
Ferrell, B.R., Smith, S.L., Ervin, K.S., Itano, J., & Melancon, C. (2003). A qualitative analysis of social concerns of women with ovarian cancer. Psycho-Oncology, 12, 647-663.
Ferrell, B.R., Smith, S.L., Juarez, G., & Melancon, C. (2003). Meaning of illness and spirituality in ovarian cancer survivors. Oncology Nursing Forum, 30, 249-257.
Ford, D., Easton, D.F., Bishop, D.T., Narod, S.A., & Goldgar, D.E. (1994). Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet, 343, 692-695.
Howell, D., Fitch, M.I., & Deane, K.A. (2003). Women's experiences with recurrent ovarian cancer. Cancer Nursing, 26, 10-17.
Markman, M. (2002). Challenging ovarian cancer: How can we improve quantity and quality of life? Medscape General Medicine, 4(4), 10.
Markman, M., & Bookman, M.A. (2000). Second-line treatment of ovarian cancer. Oncologist, 5, 26-35.
Michael, M., & Tannock, I.F. (1998). Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. Canadian Medical Association Journal, 158, 1727-1734.
Piccart, M.J., Bertelsen, K., James, K., Cassidy, J., Mangioni, C., Simonsen, E., et al. (2000). Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results. Journal of the National Cancer Institute, 92, 699-708.
Ries, L.A.G., Eisner, M.P., Kosary, C.L., Hankey, B.F., Miller, B.A., Clegg, L., et al. (Eds.). (2005). SEER cancer statistics review, 1975-2002. Bethesda, MD: National Cancer Institute. Retrieved September 27, 2005, from http://seer.cancer.gov/csr/1975_2002
Robson, M., Hensley, M., Barakat, R., Brown, C., Chi, D., Poyner, E., et al. (2003). Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecologic Oncology, 89, 281-287.
Swenson, M.M., MacLeod, J.S., Williams, S.D., Miller, A.M., & Champion, V.L. (2003). Quality of living among ovarian germ cell cancer survivors: A narrative analysis [Online exclusive]. Oncology Nursing Forum, 30, E48-E54. Retrieved September 27, 2005, from http://www.ons.org/publications/journals/ONF/volume30/issue3/3003380.asp
Trimbos, J.B., Parmar, M., Vergote, I., Guthrie, D., Bolis, G., Colombo, N., et al. (2003). International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: Two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. Journal of the National Cancer Institute, 95, 105-112.
Wenzel, C.C., Schmidinger, M.P., Locker, G.J., Jakesz, R., & Steger G.G. (2002). Relapsed, poor-prognosis ovarian cancer, individualized, interdisciplinary treatment approach, and quality of life: A case report. Supportive Care in Cancer, 10, 81-83.